US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

7.60

-0.1800-2.31%

Post-market: 7.600.00000.00%16:10 EDT

Volume:152.63K

Turnover:1.17M

Market Cap:179.62M

PE:-6.77

High:7.95

Open:7.82

Low:7.44

Close:7.78

Loading ...

Overview Company News Filings

Promising Potential of NXP900 in Combination Therapy for Resistant Lung Cancer Justifies Buy Rating

Promising Developments in Nuvectis Pharma’s NXP900 Boost Buy Rating

Nuvectis Pharma Successfully Completes Drug-Drug Interaction Study for NXP900, Paving Way for Combination with Leading Cancer Therapies

Nuvectis Pharma Inc - Nxp900 Phase 1B Program to Begin in Coming Weeks

THOMSON REUTERS

Nuvectis Pharma Inc - Nxp900 Classified as Weak Inhibitor of Cyp3a

THOMSON REUTERS

Nuvectis Pharma Inc - No Serious Adverse Events in Nxp900 Study

THOMSON REUTERS

Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting Nxp900's Potential as a Combination Partner With Leading Therapies

THOMSON REUTERS

Major Investment Alert: Nuvectis Pharma Shares Acquired by Key Shareholder

Marlio Charles Mosseri, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares

Charles Mosseri Marlio, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares

Nuvectis Pharma Inc. Conducted Annual Stockholders Meeting

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

10% Owner Marlio Charles Mosseri Reports Acquisition of Nuvectis Pharma Inc. Common Shares

10% Owner Marlio Charles Mosseri Acquires Common Shares of Nuvectis Pharma Inc

Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)

Nuvectis Pharma Q1 EPS $(0.27) Misses $(0.25) Estimate

BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million

Nuvectis Pharma Q1 EPS USD -0.27

THOMSON REUTERS

Nuvectis Pharma Inc: Extending Projected Cash Runway Into 1Q2027

THOMSON REUTERS

Press Release: Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVCT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":7.6,"timestamp":1753732800000,"preClose":7.78,"halted":0,"volume":152632,"hourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.6,"latestTime":"16:10 EDT","volume":1100,"amount":8367.0004,"timestamp":1753733404356},"delay":0,"floatShares":12714400,"shares":23634586,"eps":-1.122693,"marketStatus":"Post-Mkt","change":-0.18,"latestTime":"07-28 16:27:15 EDT","open":7.82,"high":7.95,"low":7.44,"amount":1169687.283226,"amplitude":0.065553,"askPrice":8.92,"askSize":100,"bidPrice":7.29,"bidSize":51,"shortable":3,"etf":0,"ttmEps":-1.122693,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1753747200000},"marketStatusCode":4,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":7.78,"preHourTrading":{"tag":"盘前","latestPrice":7.92,"preClose":7.78,"latestTime":"09:13 EDT","volume":594,"amount":4846.011192,"timestamp":1753708409042},"postHourTrading":{"tag":"盘后","latestPrice":7.6,"preClose":7.6,"latestTime":"16:10 EDT","volume":1100,"amount":8367.0004,"timestamp":1753733404356},"volumeRatio":0.338284,"impliedVol":1.3358,"impliedVolPercentile":0.66},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","floatShares":12714400,"roa":"-52.69%","roe":"-115.28%","lyrEps":-1.110256,"volumeRatio":0.338284,"shares":23634586,"dividePrice":0,"high":7.95,"amplitude":0.065553,"preClose":7.78,"low":7.44,"week52Low":4.44,"pbRate":"8.57","week52High":11.8,"institutionHeld":0,"latestPrice":7.6,"committee":-0.324503,"eps":-1.122693,"divideRate":0,"volume":152632,"delay":0,"ttmEps":-1.122693,"open":7.82,"prevYearClose":5.41,"prevWeekClose":7.78,"prevMonthClose":7.47,"prevQuarterClose":7.47,"fiveDayClose":7.98,"twentyDayClose":7.55,"sixtyDayClose":9.96},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVCT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550654839","title":"Promising Potential of NXP900 in Combination Therapy for Resistant Lung Cancer Justifies Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550654839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550654839?lang=en_us&edition=fundamental","pubTime":"2025-07-09 23:45","pubTimestamp":1752075914,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman has reiterated their bullish stance on NVCT stock, giving a Buy rating yesterday. Naz Rahman has given his Buy ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-nxp900-in-combination-therapy-for-resistant-lung-cancer-justifies-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-nxp900-in-combination-therapy-for-resistant-lung-cancer-justifies-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2550857587","title":"Promising Developments in Nuvectis Pharma’s NXP900 Boost Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550857587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550857587?lang=en_us&edition=fundamental","pubTime":"2025-07-09 04:55","pubTimestamp":1752008116,"startTime":"0","endTime":"0","summary":"Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Nuvectis Pharma. The associated price target remains the same with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-nuvectis-pharmas-nxp900-boost-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-nuvectis-pharmas-nxp900-boost-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2549544677","title":"Nuvectis Pharma Successfully Completes Drug-Drug Interaction Study for NXP900, Paving Way for Combination with Leading Cancer Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544677","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544677?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976038,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Successfully Completes Drug-Drug Interaction Study for NXP900, Paving Way for Combination with Leading Cancer Therapies. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on July 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL6j7XZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","NVCT","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4585","BK4588","IE00BKPKM429.USD","BK4139","LU2095319765.USD","BK4112","NDAQ","LU2210150020.SGD"],"gpt_icon":0},{"id":"2549854444","title":"Nuvectis Pharma Inc - Nxp900 Phase 1B Program to Begin in Coming Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2549854444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549854444?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA8MSXDW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2549544445","title":"Nuvectis Pharma Inc - Nxp900 Classified as Weak Inhibitor of Cyp3a","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544445?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA8MSXDW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2549544410","title":"Nuvectis Pharma Inc - No Serious Adverse Events in Nxp900 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544410?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA8MSXDW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2549443225","title":"Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting Nxp900's Potential as a Combination Partner With Leading Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2549443225","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549443225?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA8MSXDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2546263791","title":"Major Investment Alert: Nuvectis Pharma Shares Acquired by Key Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2546263791","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546263791?lang=en_us&edition=fundamental","pubTime":"2025-06-25 10:04","pubTimestamp":1750817040,"startTime":"0","endTime":"0","summary":"New insider activity at Nuvectis Pharma ( ($NVCT) ) has taken place on June 24, 2025. Significant shareholder Marlio Charles Mosseri has made a not...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investment-alert-nuvectis-pharma-shares-acquired-by-key-shareholder-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investment-alert-nuvectis-pharma-shares-acquired-by-key-shareholder-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2546255192","title":"Marlio Charles Mosseri, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2546255192","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546255192?lang=en_us&edition=fundamental","pubTime":"2025-06-25 05:15","pubTimestamp":1750799704,"startTime":"0","endTime":"0","summary":"Marlio Charles Mosseri, a 10% owner, reported an acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL4Tmg74:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Marlio Charles Mosseri, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2544495178","title":"Charles Mosseri Marlio, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2544495178","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544495178?lang=en_us&edition=fundamental","pubTime":"2025-06-20 21:51","pubTimestamp":1750427462,"startTime":"0","endTime":"0","summary":"Charles Mosseri Marlio, a 10% owner, reported an acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL5H49dh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Charles Mosseri Marlio, 10% Owner, Reports Acquisition of Nuvectis Pharma Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2543465880","title":"Nuvectis Pharma Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543465880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543465880?lang=en_us&edition=fundamental","pubTime":"2025-06-14 05:00","pubTimestamp":1749848439,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. held its 2025 Annual Meeting of Stockholders on June 12, 2025, via an online meeting platform. The election of James Oliviero as a Class III director was approved. The ratification of Kesselman & Kesselman as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL7Z0yyX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2536232814","title":"Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2536232814","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536232814?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:35","pubTimestamp":1747427713,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. , a clinical-stage biopharmaceutical company, will present at the 3rd Annual H.C. Wainwright Global BioConnect Investor Conference. The event is scheduled for May 20th, 2025, from 10:30 to 11:00 a.m. ET. Ron Bentsur, Chairman and CEO, will provide insights into the company's development of innovative precision medicines for oncology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on May 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL46ZqDl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2095319765.USD","BK4112","NVCT","LU2210149790.SGD","BK4588"],"gpt_icon":0},{"id":"2535003698","title":"10% Owner Marlio Charles Mosseri Reports Acquisition of Nuvectis Pharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2535003698","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535003698?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:37","pubTimestamp":1747175825,"startTime":"0","endTime":"0","summary":"Marlio Charles Mosseri, a 10% owner, reported an acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL3pztrQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2534546254","title":"10% Owner Marlio Charles Mosseri Acquires Common Shares of Nuvectis Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534546254","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534546254?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:54","pubTimestamp":1746831244,"startTime":"0","endTime":"0","summary":"Charles Mosseri Marlio, a 10% Owner, reported an acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDL9c6dqk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2533700982","title":"Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533700982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533700982?lang=en_us&edition=fundamental","pubTime":"2025-05-07 20:21","pubTimestamp":1746620472,"startTime":"0","endTime":"0","summary":"In a report released today, Naz Rahman from Maxim Group reiterated a Buy rating on Nuvectis Pharma (NVCT – Research Report), with a price target of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-nuvectis-pharma-nvct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-nuvectis-pharma-nvct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2533868725","title":"Nuvectis Pharma Q1 EPS $(0.27) Misses $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533868725","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533868725?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:03","pubTimestamp":1746532987,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 8 percent decrease over losses of $(0.25) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45219078/nuvectis-pharma-q1-eps-0-27-misses-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2533687496","title":"BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533687496","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533687496?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532856,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvectis Pharma Q1 Net Income USD -5.332 Million\n\n\nMay 06 (Reuters) - Nuvectis Pharma Q1 EPS USD -0.27.\n\nQ1 operating income USD -5.568 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2533687942","title":"Nuvectis Pharma Q1 EPS USD -0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2533687942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533687942?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2533668039","title":"Nuvectis Pharma Inc: Extending Projected Cash Runway Into 1Q2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2533668039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533668039?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLXDB14DB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2533268082","title":"Press Release: Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2533268082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533268082?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532800,"startTime":"0","endTime":"0","summary":"-- NXP900 clinical data presentation from the Phase 1a dose escalation study. at the 2025 American Association for Cancer Research  conference. demonstrated robust pharmacodynamic response and acceptable safety at. Cash and cash equivalents were $29.9 million as of March 31, 2025, compared to $18.5 million as of December 31, 2024. The increase of $11.4 million in cash balance in the first quarter of 2025 is a result of the Company's public offering in February 2025 with net proceeds of $14.0 million, after transaction fees and expenses, and the utilization of the at-the-market facility, partial","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"NVCT","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-02-25","symbol":"NVCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2024-11-05","symbol":"NVCT","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-08-06","symbol":"NVCT","fiscalQuarterEnding":"2024/06","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-05-07","symbol":"NVCT","fiscalQuarterEnding":"2024/03","expectedEps":-0.4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":5,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVCT","date":"2025-07-25","current":-11.453172,"percent":0.196897,"low":-4822.163542,"twenty":-11.417996,"median":-8.290504,"eighty":-5.995352,"high":-4.507629,"avg":-148.728499,"sd":704.85716,"marketCap":230907406},"quantilePoints":[{"date":"2022-02-04","current":-1722.20125,"twenty":-2416.901458,"median":-2416.901458,"eighty":-2000.081333,"marketCap":41332830},{"date":"2022-02-11","current":-3677.562083,"twenty":-3582.178633,"median":-3306.626438,"eighty":-2416.901458,"marketCap":88261490},{"date":"2022-02-18","current":-3105.261333,"twenty":-3521.769108,"median":-3195.345708,"eighty":-2596.861958,"marketCap":74526272},{"date":"2022-02-25","current":-3359.617208,"twenty":-3425.325841,"median":-3227.140208,"eighty":-2883.759766,"marketCap":80630813},{"date":"2022-03-04","current":-3990.207833,"twenty":-3634.109608,"median":-3354.318146,"eighty":-2982.322667,"marketCap":95764988},{"date":"2022-03-11","current":-4382.339833,"twenty":-4096.189467,"median":-3439.103458,"eighty":-3123.278208,"marketCap":105176156},{"date":"2022-03-18","current":-4149.180292,"twenty":-4143.881209,"median":-3592.776792,"eighty":-3195.345708,"marketCap":99580327},{"date":"2022-03-25","current":-7.409669,"twenty":-4111.026892,"median":-3439.103458,"eighty":-2883.759766,"marketCap":95510632},{"date":"2022-04-01","current":-6.926215,"twenty":-4060.1557,"median":-3354.318146,"eighty":-350.415344,"marketCap":89278913},{"date":"2022-04-08","current":-9.323751,"twenty":-4037.899584,"median":-3227.140208,"eighty":-8.266073,"marketCap":120183153},{"date":"2022-04-14","current":-9.965067,"twenty":-4016.70325,"median":-3195.345708,"eighty":-8.337111,"marketCap":128449719},{"date":"2022-04-22","current":-9.550678,"twenty":-3990.207833,"median":-3028.424667,"eighty":-9.234954,"marketCap":123108245},{"date":"2022-04-29","current":-9.373083,"twenty":-3905.422542,"median":-2416.901458,"eighty":-9.234954,"marketCap":120819043},{"date":"2022-05-06","current":-17.956854,"twenty":-3677.562083,"median":-870.079052,"eighty":-9.234954,"marketCap":231463850},{"date":"2022-05-13","current":-15.163214,"twenty":-3640.4685,"median":-14.858803,"eighty":-9.323751,"marketCap":239730416},{"date":"2022-05-20","current":-12.468425,"twenty":-3608.674042,"median":-15.011008,"eighty":-9.373083,"marketCap":197125807},{"date":"2022-05-27","current":-12.597132,"twenty":-3576.879542,"median":-14.366844,"eighty":-9.373083,"marketCap":199160654},{"date":"2022-06-03","current":-9.773637,"twenty":-3517.529842,"median":-13.793232,"eighty":-9.396762,"marketCap":154521197},{"date":"2022-06-10","current":-9.652975,"twenty":-3451.82125,"median":-12.774103,"eighty":-9.410576,"marketCap":152613528},{"date":"2022-06-17","current":-8.824428,"twenty":-3383.992992,"median":-12.70975,"eighty":-9.363217,"marketCap":139514200},{"date":"2022-06-24","current":-9.242723,"twenty":-3363.856475,"median":-12.468425,"eighty":-9.239615,"marketCap":146127453},{"date":"2022-07-01","current":-9.64493,"twenty":-3353.258333,"median":-11.474627,"eighty":-9.239615,"marketCap":152486350},{"date":"2022-07-08","current":-10.224109,"twenty":-3315.104967,"median":-10.465433,"eighty":-9.275134,"marketCap":161643161},{"date":"2022-07-15","current":-9.086265,"twenty":-3249.396358,"median":-10.409124,"eighty":-9.258683,"marketCap":143653842},{"date":"2022-07-22","current":-9.586449,"twenty":-3214.422408,"median":-10.216065,"eighty":-9.238062,"marketCap":151561766},{"date":"2022-07-29","current":-7.078848,"twenty":-3195.345708,"median":-9.9848,"eighty":-9.113213,"marketCap":111916587},{"date":"2022-08-05","current":-8.052111,"twenty":-3195.345708,"median":-9.910387,"eighty":-8.975658,"marketCap":108228426},{"date":"2022-08-12","current":-9.488582,"twenty":-3159.311958,"median":-9.805813,"eighty":-8.932791,"marketCap":127536026},{"date":"2022-08-19","current":-9.793611,"twenty":-3043.792,"median":-9.810606,"eighty":-8.975658,"marketCap":131635922},{"date":"2022-08-26","current":-9.510369,"twenty":-2917.673883,"median":-9.781681,"eighty":-9.015878,"marketCap":127828876},{"date":"2022-09-02","current":-9.031038,"twenty":-2686.842208,"median":-9.757814,"eighty":-8.975658,"marketCap":121386184},{"date":"2022-09-09","current":-9.150871,"twenty":-2416.901458,"median":-9.745482,"eighty":-8.964396,"marketCap":122996857},{"date":"2022-09-16","current":-8.932993,"twenty":-2277.961416,"median":-9.701239,"eighty":-8.937021,"marketCap":120068360},{"date":"2022-09-23","current":-8.573495,"twenty":-1381.352371,"median":-9.632337,"eighty":-8.826532,"marketCap":115236341},{"date":"2022-09-30","current":-7.723771,"twenty":-17.65393,"median":-9.586518,"eighty":-8.651931,"marketCap":103815204},{"date":"2022-10-07","current":-7.63662,"twenty":-16.210562,"median":-9.563205,"eighty":-8.405729,"marketCap":102643805},{"date":"2022-10-14","current":-7.603938,"twenty":-15.261352,"median":-9.524268,"eighty":-8.26218,"marketCap":102204531},{"date":"2022-10-21","current":-7.680195,"twenty":-15.169649,"median":-9.483135,"eighty":-8.073594,"marketCap":103229505},{"date":"2022-10-28","current":-7.810268,"twenty":-15.102332,"median":-9.471747,"eighty":-7.885,"marketCap":104977817},{"date":"2022-11-04","current":-7.576703,"twenty":-14.768455,"median":-9.451943,"eighty":-7.747738,"marketCap":101838469},{"date":"2022-11-11","current":-6.796511,"twenty":-14.399021,"median":-9.402682,"eighty":-7.680195,"marketCap":99568884},{"date":"2022-11-18","current":-7.224291,"twenty":-14.29948,"median":-9.348417,"eighty":-7.640977,"marketCap":105835867},{"date":"2022-11-25","current":-7.26627,"twenty":-14.030026,"median":-9.293004,"eighty":-7.625726,"marketCap":106450851},{"date":"2022-12-02","current":-7.506147,"twenty":-13.793232,"median":-9.25981,"eighty":-7.576703,"marketCap":109965047},{"date":"2022-12-09","current":-7.506147,"twenty":-12.999339,"median":-9.210288,"eighty":-7.516141,"marketCap":109965047},{"date":"2022-12-16","current":-7.406198,"twenty":-12.782147,"median":-9.150762,"eighty":-7.496152,"marketCap":108500799},{"date":"2022-12-23","current":-7.738527,"twenty":-12.766059,"median":-9.1187,"eighty":-7.454973,"marketCap":113369424},{"date":"2022-12-30","current":-7.496152,"twenty":-12.766059,"median":-9.099176,"eighty":-7.44634,"marketCap":109818622},{"date":"2023-01-06","current":-7.594801,"twenty":-12.732274,"median":-9.091333,"eighty":-7.450405,"marketCap":111263835},{"date":"2023-01-13","current":-7.406198,"twenty":-12.642179,"median":-9.041932,"eighty":-7.450257,"marketCap":108500799},{"date":"2023-01-20","current":-7.496152,"twenty":-12.545649,"median":-9.025531,"eighty":-7.451274,"marketCap":109818622},{"date":"2023-01-27","current":-7.975905,"twenty":-12.317195,"median":-8.981288,"eighty":-7.451274,"marketCap":116847014},{"date":"2023-02-03","current":-10.369677,"twenty":-11.855901,"median":-9.025531,"eighty":-7.452843,"marketCap":151915761},{"date":"2023-02-10","current":-14.362627,"twenty":-11.979785,"median":-9.058273,"eighty":-7.455453,"marketCap":210412480},{"date":"2023-02-17","current":-9.964884,"twenty":-11.831926,"median":-9.096402,"eighty":-7.46125,"marketCap":145985555},{"date":"2023-02-24","current":-10.434643,"twenty":-11.751993,"median":-9.101951,"eighty":-7.472325,"marketCap":152867522},{"date":"2023-03-03","current":-11.973853,"twenty":-11.789947,"median":-9.134127,"eighty":-7.486157,"marketCap":175416946},{"date":"2023-03-10","current":-8.326972,"twenty":-11.789947,"median":-9.107295,"eighty":-7.488136,"marketCap":158920261},{"date":"2023-03-17","current":-9.237161,"twenty":-11.658015,"median":-9.099176,"eighty":-7.496072,"marketCap":176291215},{"date":"2023-03-24","current":-9.086429,"twenty":-11.512116,"median":-9.107295,"eighty":-7.496152,"marketCap":173414497},{"date":"2023-03-31","current":-10.133823,"twenty":-11.492386,"median":-9.134127,"eighty":-7.496152,"marketCap":193404003},{"date":"2023-04-06","current":-9.75506,"twenty":-11.456868,"median":-9.150762,"eighty":-7.496152,"marketCap":186175325},{"date":"2023-04-14","current":-11.478815,"twenty":-11.451785,"median":-9.210288,"eighty":-7.496152,"marketCap":219073184},{"date":"2023-04-21","current":-10.705831,"twenty":-11.440849,"median":-9.236058,"eighty":-7.496152,"marketCap":204320781},{"date":"2023-04-28","current":-11.463355,"twenty":-11.463355,"median":-9.251266,"eighty":-7.496152,"marketCap":218778136},{"date":"2023-05-01","current":-12.211645,"twenty":-11.469477,"median":-9.25981,"eighty":-7.496152,"marketCap":233059240},{"date":"2023-05-12","current":-11.89369,"twenty":-11.658015,"median":-9.26808,"eighty":-7.496152,"marketCap":240145501},{"date":"2023-05-19","current":-13.141553,"twenty":-11.893853,"median":-9.303385,"eighty":-7.4981,"marketCap":265341095},{"date":"2023-05-26","current":-13.572736,"twenty":-12.376667,"median":-9.373083,"eighty":-7.505944,"marketCap":274047116},{"date":"2023-06-02","current":-13.905712,"twenty":-12.463106,"median":-9.391925,"eighty":-7.506147,"marketCap":280770234},{"date":"2023-06-09","current":-13.897784,"twenty":-12.70975,"median":-9.412549,"eighty":-7.506147,"marketCap":280610160},{"date":"2023-06-16","current":-14.42896,"twenty":-12.999339,"median":-9.452014,"eighty":-7.506147,"marketCap":291335135},{"date":"2023-06-23","current":-14.056344,"twenty":-13.239822,"median":-9.471747,"eighty":-7.514142,"marketCap":283811645},{"date":"2023-06-30","current":-12.954352,"twenty":-13.244502,"median":-9.481102,"eighty":-7.534132,"marketCap":261561324},{"date":"2023-07-07","current":-12.034704,"twenty":-13.213305,"median":-9.499475,"eighty":-7.55812,"marketCap":242992711},{"date":"2023-07-14","current":-12.082272,"twenty":-13.164951,"median":-9.548401,"eighty":-7.576348,"marketCap":243953157},{"date":"2023-07-21","current":-11.321184,"twenty":-13.104727,"median":-9.564908,"eighty":-7.580464,"marketCap":228586029},{"date":"2023-07-28","current":-11.154696,"twenty":-13.046317,"median":-9.586518,"eighty":-7.586105,"marketCap":225224469},{"date":"2023-08-04","current":-11.4956,"twenty":-13.024672,"median":-9.61481,"eighty":-7.589583,"marketCap":232107662},{"date":"2023-08-11","current":-11.568146,"twenty":-12.981344,"median":-9.64493,"eighty":-7.595321,"marketCap":258316695},{"date":"2023-08-18","current":-11.190253,"twenty":-12.938496,"median":-9.709283,"eighty":-7.5961,"marketCap":249878349},{"date":"2023-08-25","current":-11.167117,"twenty":-12.914712,"median":-9.749504,"eighty":-7.599235,"marketCap":249361716},{"date":"2023-09-01","current":-11.036011,"twenty":-12.870315,"median":-9.760327,"eighty":-7.612653,"marketCap":246434127},{"date":"2023-09-08","current":-11.151692,"twenty":-12.799405,"median":-9.777659,"eighty":-7.625726,"marketCap":249017293},{"date":"2023-09-15","current":-10.81236,"twenty":-12.778929,"median":-9.805813,"eighty":-7.625726,"marketCap":241440004},{"date":"2023-09-22","current":-10.550149,"twenty":-12.766059,"median":-9.8581,"eighty":-7.627797,"marketCap":235584825},{"date":"2023-09-29","current":-10.642694,"twenty":-12.754797,"median":-9.91491,"eighty":-7.636188,"marketCap":237651359},{"date":"2023-10-06","current":-8.38305,"twenty":-12.687226,"median":-9.900583,"eighty":-7.63662,"marketCap":187193498},{"date":"2023-10-13","current":-7.380477,"twenty":-12.582954,"median":-9.815398,"eighty":-7.63662,"marketCap":164806051},{"date":"2023-10-20","current":-6.994872,"twenty":-12.517778,"median":-9.787646,"eighty":-7.625726,"marketCap":156195494},{"date":"2023-10-27","current":-6.856054,"twenty":-12.500855,"median":-9.777659,"eighty":-7.617011,"marketCap":153095694},{"date":"2023-11-03","current":-7.295644,"twenty":-12.474627,"median":-9.75506,"eighty":-7.591323,"marketCap":162911728},{"date":"2023-11-10","current":-6.384789,"twenty":-12.465234,"median":-9.745482,"eighty":-7.564117,"marketCap":142597868},{"date":"2023-11-17","current":-6.361515,"twenty":-12.460749,"median":-9.701239,"eighty":-7.506147,"marketCap":142078070},{"date":"2023-11-24","current":-6.361515,"twenty":-12.450927,"median":-9.64493,"eighty":-7.496152,"marketCap":142078070},{"date":"2023-12-01","current":-6.594253,"twenty":-12.430299,"median":-9.61481,"eighty":-7.496152,"marketCap":147276049},{"date":"2023-12-08","current":-6.547705,"twenty":-12.335412,"median":-9.586518,"eighty":-7.486157,"marketCap":146236453},{"date":"2023-12-15","current":-6.625285,"twenty":-12.194779,"median":-9.564908,"eighty":-7.452843,"marketCap":147969112},{"date":"2023-12-22","current":-6.260661,"twenty":-12.140939,"median":-9.548401,"eighty":-7.432254,"marketCap":139825613},{"date":"2023-12-29","current":-6.648559,"twenty":-12.098128,"median":-9.517319,"eighty":-7.416193,"marketCap":148488910},{"date":"2024-01-05","current":-6.4934,"twenty":-12.093462,"median":-9.488582,"eighty":-7.408281,"marketCap":145023591},{"date":"2024-01-12","current":-7.54848,"twenty":-12.085504,"median":-9.474718,"eighty":-7.408281,"marketCap":168587759},{"date":"2024-01-19","current":-6.439094,"twenty":-12.082272,"median":-9.46188,"eighty":-7.391646,"marketCap":143810730},{"date":"2024-01-26","current":-5.996891,"twenty":-12.063245,"median":-9.451871,"eighty":-7.358883,"marketCap":133934571},{"date":"2024-02-02","current":-5.539173,"twenty":-12.010364,"median":-9.403927,"eighty":-7.324002,"marketCap":123711881},{"date":"2024-02-09","current":-5.345224,"twenty":-11.96331,"median":-9.373083,"eighty":-7.303747,"marketCap":119380232},{"date":"2024-02-16","current":-6.105503,"twenty":-11.93164,"median":-9.313568,"eighty":-7.27802,"marketCap":136360294},{"date":"2024-02-23","current":-5.787427,"twenty":-11.905064,"median":-9.279216,"eighty":-7.226222,"marketCap":129256391},{"date":"2024-03-01","current":-7.657092,"twenty":-11.893853,"median":-9.25981,"eighty":-7.201903,"marketCap":171013482},{"date":"2024-03-08","current":-8.110119,"twenty":-11.888595,"median":-9.239942,"eighty":-7.226222,"marketCap":180531251},{"date":"2024-03-15","current":-7.303897,"twenty":-11.863459,"median":-9.185622,"eighty":-7.234415,"marketCap":162584739},{"date":"2024-03-22","current":-7.224073,"twenty":-11.84433,"median":-9.144455,"eighty":-7.224117,"marketCap":160807857},{"date":"2024-03-28","current":-6.657322,"twenty":-11.84392,"median":-9.1187,"eighty":-7.196306,"marketCap":148191992},{"date":"2024-04-05","current":-6.154431,"twenty":-11.813935,"median":-9.096402,"eighty":-7.141402,"marketCap":136997633},{"date":"2024-04-12","current":-5.922941,"twenty":-11.807221,"median":-9.086347,"eighty":-7.106352,"marketCap":131844674},{"date":"2024-04-19","current":-5.364173,"twenty":-11.73344,"median":-9.082564,"eighty":-7.087417,"marketCap":119406497},{"date":"2024-04-26","current":-5.196543,"twenty":-11.725512,"median":-9.036485,"eighty":-7.056377,"marketCap":115675044},{"date":"2024-05-03","current":-5.5789,"twenty":-11.693997,"median":-9.020144,"eighty":-6.994872,"marketCap":124186324},{"date":"2024-05-10","current":-5.232404,"twenty":-11.670016,"median":-8.943064,"eighty":-6.926009,"marketCap":117111662},{"date":"2024-05-17","current":-5.355423,"twenty":-11.568146,"median":-8.86763,"eighty":-6.867017,"marketCap":119865071},{"date":"2024-05-24","current":-5.478442,"twenty":-11.551096,"median":-8.824241,"eighty":-6.807818,"marketCap":122618480},{"date":"2024-05-31","current":-5.248806,"twenty":-11.540057,"median":-8.78056,"eighty":-6.750346,"marketCap":117478784},{"date":"2024-06-07","current":-5.355423,"twenty":-11.535651,"median":-8.71467,"eighty":-6.643904,"marketCap":119865071},{"date":"2024-06-14","current":-5.601461,"twenty":-11.522593,"median":-8.700328,"eighty":-6.585481,"marketCap":125371889},{"date":"2024-06-21","current":-5.601461,"twenty":-11.514132,"median":-8.595282,"eighty":-6.550808,"marketCap":125371889},{"date":"2024-06-28","current":-5.14219,"twenty":-11.514103,"median":-8.591276,"eighty":-6.544445,"marketCap":115092496},{"date":"2024-07-05","current":-5.084781,"twenty":-11.509505,"median":-8.549205,"eighty":-6.524432,"marketCap":113807572},{"date":"2024-07-12","current":-5.248806,"twenty":-11.505115,"median":-8.477607,"eighty":-6.501158,"marketCap":117478784},{"date":"2024-07-15","current":-5.396429,"twenty":-11.504671,"median":-8.471907,"eighty":-6.499606,"marketCap":120782874},{"date":"2024-08-02","current":-5.068379,"twenty":-11.504226,"median":-8.439046,"eighty":-6.4934,"marketCap":113440450},{"date":"2024-08-09","current":-6.04608,"twenty":-11.4956,"median":-8.380128,"eighty":-6.446852,"marketCap":127584385},{"date":"2024-08-16","current":-5.568758,"twenty":-11.4956,"median":-8.33936,"eighty":-6.431336,"marketCap":117511934},{"date":"2024-08-23","current":-6.364295,"twenty":-11.487672,"median":-8.317646,"eighty":-6.400304,"marketCap":134299353},{"date":"2024-08-30","current":-6.001884,"twenty":-11.478815,"median":-8.282792,"eighty":-6.361515,"marketCap":126651751},{"date":"2024-09-06","current":-5.445008,"twenty":-11.472569,"median":-8.234715,"eighty":-6.361515,"marketCap":114900558},{"date":"2024-09-13","current":-5.745544,"twenty":-11.464886,"median":-8.172852,"eighty":-6.350611,"marketCap":121242472},{"date":"2024-09-20","current":-5.966527,"twenty":-11.457439,"median":-8.106128,"eighty":-6.299451,"marketCap":125905644},{"date":"2024-09-27","current":-5.445008,"twenty":-11.447214,"median":-8.0288,"eighty":-6.249174,"marketCap":114900558},{"date":"2024-10-04","current":-5.445008,"twenty":-11.428314,"median":-7.993998,"eighty":-6.196292,"marketCap":114900558},{"date":"2024-10-11","current":-5.471526,"twenty":-11.41595,"median":-7.975905,"eighty":-6.137667,"marketCap":115460138},{"date":"2024-10-18","current":-5.975366,"twenty":-11.389225,"median":-7.92057,"eighty":-6.076134,"marketCap":126092170},{"date":"2024-10-25","current":-7.734386,"twenty":-11.342169,"median":-7.870838,"eighty":-6.088277,"marketCap":163211020},{"date":"2024-10-31","current":-6.974207,"twenty":-11.32549,"median":-7.854682,"eighty":-6.099297,"marketCap":147169708},{"date":"2024-11-08","current":-8.029494,"twenty":-11.299815,"median":-7.828418,"eighty":-6.086567,"marketCap":155563417},{"date":"2024-11-15","current":-5.516667,"twenty":-11.283906,"median":-7.854682,"eighty":-6.086567,"marketCap":106879902},{"date":"2024-11-22","current":-4.886589,"twenty":-11.259662,"median":-7.803133,"eighty":-6.007187,"marketCap":94672767},{"date":"2024-11-29","current":-5.026205,"twenty":-11.229851,"median":-7.772793,"eighty":-5.982437,"marketCap":97377703},{"date":"2024-12-06","current":-4.746972,"twenty":-11.207233,"median":-7.743226,"eighty":-5.930799,"marketCap":91967831},{"date":"2024-12-13","current":-4.6273,"twenty":-11.199507,"median":-7.732114,"eighty":-5.891293,"marketCap":89649314},{"date":"2024-12-20","current":-4.677163,"twenty":-11.187168,"median":-7.695034,"eighty":-5.858687,"marketCap":90615363},{"date":"2024-12-27","current":-5.00626,"twenty":-11.179456,"median":-7.680195,"eighty":-5.833974,"marketCap":96991284},{"date":"2025-01-03","current":-5.375247,"twenty":-11.167117,"median":-7.680195,"eighty":-5.765486,"marketCap":104140044},{"date":"2025-01-10","current":-6.153113,"twenty":-11.15718,"median":-7.674115,"eighty":-5.765219,"marketCap":119210403},{"date":"2025-01-17","current":-5.445056,"twenty":-11.152293,"median":-7.657092,"eighty":-5.745544,"marketCap":105492512},{"date":"2025-01-24","current":-6.402428,"twenty":-11.143981,"median":-7.63662,"eighty":-5.743678,"marketCap":124040646},{"date":"2025-01-31","current":-6.721552,"twenty":-11.137297,"median":-7.62606,"eighty":-5.745544,"marketCap":130223358},{"date":"2025-02-07","current":-8.933023,"twenty":-11.094623,"median":-7.625726,"eighty":-5.756709,"marketCap":173068391},{"date":"2025-02-14","current":-8.575209,"twenty":-11.04835,"median":-7.63608,"eighty":-5.764953,"marketCap":166136094},{"date":"2025-02-21","current":-9.278499,"twenty":-11.027345,"median":-7.63662,"eighty":-5.774262,"marketCap":179761644},{"date":"2025-02-28","current":-8.442054,"twenty":-11.010673,"median":-7.657749,"eighty":-5.790095,"marketCap":160399020},{"date":"2025-03-07","current":-7.571459,"twenty":-11.00084,"median":-7.658407,"eighty":-5.794098,"marketCap":143857718},{"date":"2025-03-14","current":-10.279948,"twenty":-10.991897,"median":-7.680195,"eighty":-5.810034,"marketCap":195319016},{"date":"2025-03-21","current":-11.51108,"twenty":-11.024301,"median":-7.680195,"eighty":-5.833952,"marketCap":218710515},{"date":"2025-03-28","current":-11.880419,"twenty":-11.05452,"median":-7.709402,"eighty":-5.833974,"marketCap":225727965},{"date":"2025-04-04","current":-11.14174,"twenty":-11.147711,"median":-7.734386,"eighty":-5.837495,"marketCap":211693065},{"date":"2025-04-11","current":-10.495396,"twenty":-11.14058,"median":-7.744393,"eighty":-5.846312,"marketCap":199412528},{"date":"2025-04-17","current":-10.710844,"twenty":-11.149702,"median":-7.758662,"eighty":-5.855152,"marketCap":203506041},{"date":"2025-04-25","current":-13.493202,"twenty":-11.164633,"median":-7.795998,"eighty":-5.871062,"marketCap":256370829},{"date":"2025-05-02","current":-11.843485,"twenty":-11.207752,"median":-7.810247,"eighty":-5.879113,"marketCap":225026220},{"date":"2025-05-09","current":-10.697367,"twenty":-11.237045,"median":-7.846568,"eighty":-5.884079,"marketCap":215669620},{"date":"2025-05-16","current":-10.878873,"twenty":-11.207752,"median":-7.868697,"eighty":-5.889786,"marketCap":219328958},{"date":"2025-05-23","current":-11.664309,"twenty":-11.314061,"median":-7.913104,"eighty":-5.895991,"marketCap":235164130},{"date":"2025-05-30","current":-10.960933,"twenty":-11.324344,"median":-7.941649,"eighty":-5.896706,"marketCap":220983379},{"date":"2025-06-06","current":-10.515462,"twenty":-11.324344,"median":-7.987178,"eighty":-5.92233,"marketCap":212002236},{"date":"2025-06-13","current":-10.351341,"twenty":-11.321184,"median":-8.017247,"eighty":-5.922941,"marketCap":208693394},{"date":"2025-06-20","current":-9.436953,"twenty":-11.292692,"median":-8.029494,"eighty":-5.938657,"marketCap":190258417},{"date":"2025-06-27","current":-9.038374,"twenty":-11.283352,"median":-8.106128,"eighty":-5.948792,"marketCap":182222658},{"date":"2025-07-03","current":-8.839084,"twenty":-11.259662,"median":-8.16619,"eighty":-5.960054,"marketCap":178204778},{"date":"2025-07-11","current":-12.134732,"twenty":-11.299815,"median":-8.221117,"eighty":-5.97183,"marketCap":244648338},{"date":"2025-07-18","current":-11.779136,"twenty":-11.352391,"median":-8.261696,"eighty":-5.985973,"marketCap":237479156},{"date":"2025-07-25","current":-11.453172,"twenty":-11.417996,"median":-8.290504,"eighty":-5.995352,"marketCap":230907406}],"updateTime":1753710979289}}}